Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $7.3500 (0.68%) ($6.8400 - $7.7800) on Mon. Mar. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.61% (three month average) | RSI | 18 | Latest Price | $7.3500(0.68%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ANPC declines -10.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) LIT(11%) XLB(11%) IPO(10%) ONLN(9%) BOTZ(8%) | Factors Impacting ANPC price | ANPC will decline at least -2.805% in a week (0% probabilities). SHY(-9%) VIXM(-3%) TBT(-3%) XBI(-1%) VXX(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.805% (StdDev 5.61%) | Hourly BBV | 0 () | Intraday Trend | 7.5% | | | |
|
1 - 5 Day Possible Target | $-15.57(-311.84%) | Resistance Level | $8.42 | 5 Day Moving Average | $7.33(0.27%) | 10 Day Moving Average | $7.52(-2.26%) | 20 Day Moving Average | $8.42(-12.71%) | To recent high | -34.7% | To recent low | 4% | Market Cap | $63m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |